Massachusetts Financial Services’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9,126
Closed -$626K – 1085
2026
Q2
$626K Sell
9,126
-349,852
-97% -$19.9M ﹤0.01% 935
2026
Q1
$23.1M Buy
358,978
+160,052
+80% +$14.6M 0.01% 612
2025
Q4
$25.9M Sell
198,926
-10,329
-5% -$1.42M 0.01% 602
2025
Q3
$22.5M Sell
209,255
-25,830
-11% -$2.81M 0.01% 615
2025
Q2
$21.7M Buy
+235,085
New +$18.5M 0.01% 606

Other funds holding WGS

Massachusetts Financial Services's WGS Position: Q3 2026 in Review

Massachusetts Financial Services sold out of GeneDx Holdings (WGS) in Q3 2026, closing a stake of 9,126 shares — an estimated $626K sold.

Massachusetts Financial Services first reported a position in WGS in Q2 2025 and held it in 5 quarters. The position peaked at $25.9M in Q4 2025. 152 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Massachusetts Financial Services reported no remaining GeneDx Holdings position as of Q3 2026 after selling out during the quarter.
  • Massachusetts Financial Services sold 9,126 GeneDx Holdings shares in Q3 2026, an estimated $626K.
  • Massachusetts Financial Services first reported a position in GeneDx Holdings in Q2 2025 and held it in 5 quarters.
  • Massachusetts Financial Services's GeneDx Holdings position peaked at $25.9M in Q4 2025.
  • 152 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.